The icatibant outcome survey: more than 2900 icatibant-treated attacks in patients with type I or II hereditary angioedema

被引:0
|
作者
Maurer, M. [1 ]
Caballero, T. [2 ]
Aberer, W. [3 ]
Zanichelli, A. [4 ]
Bouillet, L. [5 ]
Fabien, V [6 ]
Andresen, I [6 ]
Longhurst, H. J. [7 ]
机构
[1] Charite Univ Med Berlin, Allergie Ctr Charite, Dept Dermatol & Allergy, Berlin, Germany
[2] Hosp La Paz, Inst Hlth Res IdiPAZ, Dept Allergy, Madrid, Spain
[3] Med Univ Graz, Dept Dermatol & Venereol, Graz, Austria
[4] Univ Milan, Osped Luigi Sacco, Dipartimento Sci Biomed & Clin Luigi Sacco, Milan, Italy
[5] Grenoble Univ Hosp, Natl Reference Ctr Angioedema, Dept Internal Med, Grenoble, France
[6] Shire, Zug, Switzerland
[7] Barts Hlth NHS Trust, Dept Immunol, London, England
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
513
引用
收藏
页码:242 / 242
页数:1
相关论文
共 50 条
  • [41] Type 2 hereditary angioedema treated with acute exacerbation with icatibant: A case report
    Hwang, Yu-Kyoung
    An, Kyeong Min
    Kim, Yong Hyun
    Kim, Sae-Hoon
    Chang, Yoon-Seok
    [J]. ALLERGY ASTHMA & RESPIRATORY DISEASE, 2021, 9 (03): : 180 - 183
  • [42] Variability of disease activity in patients with hereditary angioedema type 1/2: longitudinal data from the Icatibant Outcome Survey
    Maurer, M.
    Caballero, T.
    Aberer, W.
    Zanichelli, A.
    Bouillet, L.
    Bygum, A.
    Grumach, A. S.
    Botha, J.
    Andresen, I.
    Longhurst, H. J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (12) : 2421 - 2430
  • [43] Hereditary angioedema presents in childhood but is diagnosed in adulthood findings from the Icatibant outcome survey
    Longhurst, H.
    Aberer, W.
    Bouillet, L.
    Caballero, T.
    Bygum, A.
    Grumach, A. S.
    Fabien, V
    Andresen, I
    Zanichelli, A.
    Maurer, M.
    [J]. ALLERGY, 2016, 71 : 243 - 243
  • [44] Rapid and sustainable effect of icatibant across recurrent hereditary angioedema attacks in adolescent patients
    Kessel, A.
    Farkas, H.
    Reshef, A.
    Caballero, T.
    Ortega-Lopez, M. C.
    Vardi, M.
    Hao, J.
    Aberer, W.
    [J]. ALLERGY, 2019, 74 : 213 - 214
  • [45] Short-term prophylactic treatment of hereditary angioedema type II with icatibant
    Clemens, P.
    [J]. ALLERGY, 2011, 66 : 429 - 429
  • [46] The Icatibant Outcome Survey: experience of hereditary angioedema management from four European countries
    Caballero, T.
    Aberer, W.
    Longhurst, H.
    Maurer, M.
    Zanichelli, A.
    Fabien, V
    Bouillet, L.
    [J]. ALLERGY, 2014, 69 : 54 - 54
  • [47] The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries
    Caballero, T.
    Aberer, W.
    Longhurst, H. J.
    Maurer, M.
    Zanichelli, A.
    Perrin, A.
    Bouillet, L.
    Andresen, I.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (07) : 1214 - 1222
  • [48] Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
    Zanichelli, Andrea
    Magerl, Markus
    Longhurst, Hilary J.
    Aberer, Werner
    Caballero, Teresa
    Bouillet, Laurence
    Bygum, Anette
    Grumach, Anete S.
    Botha, Jaco
    Andresen, Irmgard
    Maurer, Marcus
    [J]. CLINICAL AND TRANSLATIONAL ALLERGY, 2018, 8
  • [49] Successful treatment of acute hereditary angioedema attacks with icatibant in patients with venous access problems
    Wiednig, M.
    Aberer, W.
    [J]. ALLERGY, 2011, 66 : 428 - 428
  • [50] PATIENTS' OPINIONS OF SELF-ADMINISTERED ICATIBANT FOR THE TREATMENT OF ACUTE HEREDITARY ANGIOEDEMA ATTACKS
    Toubi, E.
    Aberer, W.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A112 - A113